DigestRedComo funciona
Red
/
Empresas
Al
No verificado

Alveus Therapeutics Inc

Sobre qué escribimos

Anuncios brevesFinanzasMedicina Salud Bienestar

5 Comunicados de prensa

Ver todos los comunicados de prensa
14/09/2026
Medicina Salud Bienestar
Alveus Therapeutics Initiates Phase 2 PRESERVE Trial to Evaluate ALV-100 for Chronic Weight Management
Fuente
Alveus Therapeutics Inc
Editor
GLOBENEWSWIRE
1.00
0
01/09/2026
Medicina Salud Bienestar
Alveus Therapeutics Strengthens Executive Leadership Team, Opens Boston office
Fuente
Alveus Therapeutics Inc
Editor
GLOBENEWSWIRE
1.00
0
24/02/2026
Medicina Salud Bienestar
Finanzas
Alveus Therapeutics Announces Second and Final Closing of Oversubscribed Series A, Bringing Total Financing to $197 Million to Advance Next‑Generation Therapies for Obesity and Metabolic Diseases
Fuente
Alveus Therapeutics Inc
Editor
GLOBENEWSWIRE
1.00
0
23/01/2026
Medicina Salud Bienestar
Anuncios breves
Alveus Therapeutics Announces FDA Clearance of IND and First Patient Dosed in Phase 1b Trial of ALV-100 for Obesity
Fuente
Alveus Therapeutics Inc
Editor
GLOBENEWSWIRE
1.00
0
08/01/2026
Medicina Salud Bienestar
Finanzas
Alveus Therapeutics Launches with $160 Million Series A Financing to Advance Next-Generation Therapies for Obesity and Metabolic Diseases
Fuente
Alveus Therapeutics Inc
Editor
GLOBENEWSWIRE
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0